EUDA vs. SLNO

In the year-to-date period, EUDA achieves a 214.74% return, which is significantly higher than SLNO's 12.25% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for EUDA Health Holdings Limited (EUDA) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EUDA Sharpe Ratio is 2.54, which is higher than the SLNO Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of EUDA and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither EUDA nor SLNO has paid dividends to shareholders.

The maximum EUDA drawdown since its inception was -95.02%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for EUDA and SLNO. For additional features, visit the drawdowns tool.

EUDA Health Holdings Limited (EUDA) has a higher volatility of 34.57% compared to Soleno Therapeutics, Inc. (SLNO) at 12.79%. This indicates that EUDA's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between EUDA Health Holdings Limited and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.